With the long-term goal of better understanding the role of the gastrointestinal peptide hormone cholecystokinin (CCK) in health and disease, the current proposal focuses on the structure, function and regulation of the type of CCK receptor found on classical gastrointestinal targets such as pancreas and gallbladder, the Type A CCK receptor. This is known to be important physiologically and is potentially important in the pathogenesis of digestive dysfunctional states. Our general hypothesis is that the structure of this receptor will provide insight into the molecular basis for its initiation of signalling cascades within the cell and for receptor regulation. We will test the specific hypothesis that the CCK-binding subunit follows the structural motif of other guanine nucleotide-binding protein (G-p)- associated receptors, with seven transmembrane segments, and domains which are glycosylated, cysteine-rich, phosphorylated, and fatty acid- acrylated. This will be accomplished using approaches of affinity labeling, enzymatic digestion, affinity chromatography, precursor incorporation in biosynthesis, and purification with chemical characterization. Unlike most G-p-coupled receptors cloned, CCK has trophic effects on the acinar cell, suggesting the possibility of its receptor having additional novel domains. Particular attention will be directed toward the processes of receptor phosphorylation and fatty acid acylation, since these have potentially profound functional and regulatory roles. Affinity labeling probes with photolabile and chemically-reactive moieties within the receptor binding domain will be used to identify domains, and possibly residues, within the active site of this receptor. Partial amino acid sequencing of some of these domains will be performed, and used as a basis for cDNA cloning strategies and for generation of site-specific receptor antibodies. While this structural motif also carries predictions for receptor function and regulation, because of the growth factor activity and unusual biphasic dose-response curve of CCK, new regulatory themes may exist as well. Novel analogues of CCK exist, which will be used to dissect the intracellular events involved in these processes, and to help test a new model for the function and regulation of this receptor. This model predicts the sequential existence of two affinity states of one receptor molecule, two independently initiated intracellular activation cascades, and the presence and sites of regulation of this receptor. This model predicts the sequential existence of two affinity states of one receptor molecule, two independently initiated intracellular activation cascades, and the presence and sites of regulation of a CCK receptor kinase and phosphatase. Focus will be directed toward the molecular basis of receptor affinity state, the role of G-p-association in biological responses, and mechanisms of receptor desensitization, including uncoupling, sequestration, and down-regulation. This should establish a paradigm for future investigation of other types of CCK/gastrin receptors, and to thereby gain insights into the molecular basis of ligand-receptor interaction and cell activation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK032878-12
Application #
2138897
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1983-08-01
Project End
1996-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
12
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Desai, A J; Dong, M; Harikumar, K G et al. (2016) Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor. Int J Obes Suppl 6:S22-S27
Miller, Laurence J; Desai, Aditya J (2016) Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target. Trends Endocrinol Metab 27:609-619
Desai, Aditya J; Dong, Maoqing; Miller, Laurence J (2016) Beneficial effects of ?-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol. Clin Nutr 35:1374-1379
Desai, Aditya J; Henke, Brad R; Miller, Laurence J (2015) Elimination of a cholecystokinin receptor agonist 'trigger' in an effort to develop positive allosteric modulators without intrinsic agonist activity. Bioorg Med Chem Lett 25:1849-55
Harikumar, Kaleeckal G; Miller, Laurence J (2015) Use of Fluorescence Indicators in Receptor Ligands. Methods Mol Biol 1335:115-30
Desai, Aditya J; Lam, Polo C H; Orry, Andrew et al. (2015) Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex. J Med Chem 58:9562-77
Desai, Aditya J; Dong, Maoqing; Harikumar, Kaleeckal G et al. (2015) Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function. Am J Physiol Gastrointest Liver Physiol 309:G377-86
Dong, Maoqing; Vattelana, Ashton M; Lam, Polo C-H et al. (2015) Development of a highly selective allosteric antagonist radioligand for the type 1 cholecystokinin receptor and elucidation of its molecular basis of binding. Mol Pharmacol 87:130-40
Desai, Aditya J; Harikumar, Kaleeckal G; Miller, Laurence J (2014) A type 1 cholecystokinin receptor mutant that mimics the dysfunction observed for wild type receptor in a high cholesterol environment. J Biol Chem 289:18314-26
Dong, Maoqing; Miller, Laurence J (2013) Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling. Peptides 46:143-9

Showing the most recent 10 out of 130 publications